Literature DB >> 18000836

Simple and sensitive quantification of bioactive peptides in biological matrices using liquid chromatography/selected reaction monitoring mass spectrometry coupled with trichloroacetic acid clean-up.

Naoaki Murao1, Masaki Ishigai, Hideyuki Yasuno, Yasushi Shimonaka, Yoshinori Aso.   

Abstract

A simple and sensitive liquid chromatography/electrospray ionization tandem mass spectrometric (LC/ESI-MS/MS) method has been developed for the quantification of bioactive peptides in biological fluids. The method employs protein precipitation with 4% trichloroacetic acid (TCA) and selected reaction monitoring (SRM) using an immonium ion as the product ion. This method was applied to determine the synthetic parathyroid hormone (PTH) analog (MW 1721) in rat plasma and human hepcidin-25 (MW 2789) in human serum. TCA clean-up showed a sufficient recovery for peptides with a MW of less than 3000, and would be useful as a simple and rapid method because of direct injection of the supernatant without evaporation or dilution. In addition, TCA clean-up allowed us not only to reduce sample preparation time, but also to select an immonium ion as a product ion of SRM, which led to detection more sensitive than SRM using other types of product ions. The lower limits of quantitation (LLOQs) of the PTH analog and the human hepcidin-25 were 0.2 ng/mL and 5 ng/mL, respectively. This method was fully validated with acceptable linearity, intra- and inter-assay precisions, and accuracy. Furthermore, this simple and rapid method is applicable to pharmacokinetic studies. Copyright (c) 2007 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18000836     DOI: 10.1002/rcm.3319

Source DB:  PubMed          Journal:  Rapid Commun Mass Spectrom        ISSN: 0951-4198            Impact factor:   2.419


  27 in total

1.  Measurement of serum hepcidin-25 levels as a potential test for diagnosing hemochromatosis and related disorders.

Authors:  Yoshibumi Kaneko; Hiroaki Miyajima; Alberto Piperno; Naohisa Tomosugi; Hisao Hayashi; Natsuko Morotomi; Ken-ichi Tsuchida; Takaaki Ikeda; Akihisa Ishikawa; Yusuke Ota; Shinya Wakusawa; Kentaro Yoshioka; Satoshi Kono; Sara Pelucchi; Ai Hattori; Yasuaki Tatsumi; Toshihide Okada; Masakazu Yamagishi
Journal:  J Gastroenterol       Date:  2010-06-09       Impact factor: 7.527

Review 2.  Modulation of hepcidin to treat iron deregulation: potential clinical applications.

Authors:  Nicole L Blanchette; David H Manz; Frank M Torti; Suzy V Torti
Journal:  Expert Rev Hematol       Date:  2015-12-15       Impact factor: 2.929

3.  Results of the first international round robin for the quantification of urinary and plasma hepcidin assays: need for standardization.

Authors:  Joyce J C Kroot; Erwin H J M Kemna; Sukhvinder S Bansal; Mark Busbridge; Natascia Campostrini; Domenico Girelli; Robert C Hider; Vasiliki Koliaraki; Avgi Mamalaki; Gordana Olbina; Naohisa Tomosugi; Chris Tselepis; Douglas G Ward; Tomas Ganz; Jan C M Hendriks; Dorine W Swinkels
Journal:  Haematologica       Date:  2009-12       Impact factor: 9.941

4.  The effect of frequency of C.E.R.A. administration on the contribution of dietary iron for erythropoiesis.

Authors:  Yukari Matsuo-Tezuka; Mariko Noguchi-Sasaki; Mitsue Kurasawa; Keigo Yorozu; Yasushi Shimonaka
Journal:  Int J Hematol       Date:  2017-03-14       Impact factor: 2.490

5.  Erythropoietin stimulation decreases hepcidin expression through hematopoietic activity on bone marrow cells in mice.

Authors:  Yusuke Sasaki; Mariko Noguchi-Sasaki; Hideyuki Yasuno; Keigo Yorozu; Yasushi Shimonaka
Journal:  Int J Hematol       Date:  2012-11-16       Impact factor: 2.490

6.  Mechanism underlying the transient increase of serum iron during FOLFOX/FOLFIRI therapy.

Authors:  Takumi Ochiai; Kazuhiko Nishimura; Tomoo Watanabe; Masayuki Kitajima; Akinori Nakatani; Tsuyoshi Sato; Kenji Kishine; Shunji Futagawa; Satomi Mashiko; Isao Nagaoka
Journal:  Mol Clin Oncol       Date:  2014-08-11

Review 7.  Molecular mechanisms of hepcidin regulation: implications for the anemia of CKD.

Authors:  Jodie L Babitt; Herbert Y Lin
Journal:  Am J Kidney Dis       Date:  2010-02-26       Impact factor: 8.860

8.  Systemic administration of C-type natriuretic peptide as a novel therapeutic strategy for skeletal dysplasias.

Authors:  Akihiro Yasoda; Hidetomo Kitamura; Toshihito Fujii; Eri Kondo; Naoaki Murao; Masako Miura; Naotetsu Kanamoto; Yasato Komatsu; Hiroshi Arai; Kazuwa Nakao
Journal:  Endocrinology       Date:  2009-03-12       Impact factor: 4.736

9.  Hepcidin production in response to iron is controlled by monocyte-derived humoral factors.

Authors:  Yusuke Sasaki; Yasushi Shimonaka; Katsuya Ikuta; Takaaki Hosoki; Katsunori Sasaki; Yoshihiro Torimoto; Hirotaka Kanada; Yoshiyuki Moriguchi; Yutaka Kohgo
Journal:  Int J Hematol       Date:  2013-12-01       Impact factor: 2.490

10.  Reduction of a marker of oxidative stress with enhancement of iron utilization by erythropoiesis activation following epoetin beta pegol administration in iron-loaded db/db mice.

Authors:  Mariko Noguchi-Sasaki; Yusuke Sasaki; Yukari Matsuo-Tezuka; Hideyuki Yasuno; Mitsue Kurasawa; Keigo Yorozu; Yasushi Shimonaka
Journal:  Int J Hematol       Date:  2016-01-06       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.